Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Paolo Sbarzaglia , Salvatore Notaristefano , Claudio Cavallini Added: 3 years ago
Saphenous vein grafts (SVG) have been extensively used in coronary artery bypass surgery (CABG) as additional conduits to arterial grafts. However, it is well known that vein grafts may develop degenerative processes that may result in stenosis or occlusion1 in 12–20% of patients at the end of the first year and approximately 50% by 10 years.2 The main causes of graft disease are intimal… View more
Author(s): Konstantinidis Nikolaos , Sianos Georgios Added: 3 years ago
Saphenous vein grafts (SVGs), despite their inherent inferiority to arterial conduits, still remain the type of grafts most commonly used during coronary artery bypass grafting (CABG).1 The natural and post-interventional biological behaviour of SVGs differ from that of native coronary vessels, increasing the risk of restenosis.2 SVG disease after CABG is a strong predictor of mortality.3 In a… View more
Author(s): Jennifer Franke , Horst Sievert Added: 3 years ago
After having performed angioplasty in coronary and peripheral vascular disease with excellent results, carotid angioplasty was thought to be an opportunity to simplify the treatment of carotid stenosis. Up until then there was no apparent reason to protect patients against distal embolisation. With the development of carotid angioplasty and stenting, prevention of distal embolisation of… View more
Author(s): Robert-Jan van Geuns , Katherin Awad , Alexander IJsselmuiden , et al Added: 3 years ago
Significant advances have been made with new generation stents to further improve the results of percutaneous coronary intervention (PCI) and outcomes for patients. Drug-eluting stents introduced in the early 2000s, thinner strut stent platforms, and bioabsorbable polymers and stents are among these developments.1 Despite these advances, there remain some areas where optimal stenting continues to… View more
Author(s): John Rawlins , Jehangir Din , Suneel Talwar , et al Added: 3 years ago
The introduction of lasers for the treatment of vascular atherosclerosis began in the 1980s, initially for the treatment of critical limb ischaemia,1 followed by trials that supported its use in coronary circulation.2–5 However, catheters and technique were rudimentary and associated with complications.6,7 Refinements in catheter technology8 and introduction of safe lasing techniques9,10 have led… View more
Author(s): J Raider Estrada , Jonathan D Paul , Atman P Shah , et al Added: 3 years ago
While the breadth of procedural offerings in interventional cardiology (IC) has exponentially expanded over the past four decades to include cardiac structural, peripheral arterial, and venous interventions, percutaneous coronary intervention (PCI) remains at the core of the field, accounting for the greatest percentage of therapeutic catheter-based procedures performed by IC practitioners in the… View more
Author(s): William R Colyer Jr , Christopher J Cooper Added: 3 years ago
Atherosclerotic renal artery stentosis (RAS) is a frequently recognised cause of secondary hypertension and chronic kidney disease.1–4 Revascularisation of RAS with angioplasty and stenting is often performed with the goals of improved blood pressure control and preserving or improving renal function.5 However, renal artery stenting is sometimes associated with acute worsening of renal function.6… View more
Author(s): Salvatore Brugaletta , Hector M Garcia-Garcia , Patrick W Serruys Added: 3 years ago
The identification of vulnerable plaques has been a longstanding challenge for interventional cardiologists. Plaque composition is regarded as an important feature for assessment of plaque vulnerability. Histopathologists have in particular shown that the type of plaque most commonly prone to rupture in vivo is the thin-cap fibroatheroma (TCFA), in which the presence of lipid core (also called… View more